Table 5. Measurement of foot paw diameter .
Groups | Treatment and dose | Paw diameter (mm) | Percentage inhibition (%) | |
2nd day | 6th day | |||
I | Normal control | 1.57 ± 0.03 | 3.95 ± 0.02 | |
II | DSS control | 1.42 ± 0.01 | 6.26 ± 0.01 | |
III | MFS-LD | 1.45 ± 0.02* | 2.20 ± 0.02** | 45 |
IV | MFS-HD | 1.20 ± 0.01** | 1.18 ± 0.02* | 71 |
V | Mesalazine | 1.22 ± 0.01** | 1.18 ± 0.02* | 71 |
Values are mean ± SEM; n=6; ** P < 0.001 vs. Normal control; * P < 0.05 vs. DSS control.